vs
Side-by-side financial comparison of LCNB CORP (LCNB) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
LCNB CORP is the larger business by last-quarter revenue ($23.9M vs $13.2M, roughly 1.8× TriSalus Life Sciences, Inc.). LCNB CORP runs the higher net margin — 23.7% vs -73.9%, a 97.6% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 5.1%). LCNB CORP produced more free cash flow last quarter ($33.4M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 15.7%).
LCNB Corp is a United States-based financial holding company that operates through its national bank subsidiary, providing a full suite of retail and commercial banking products and services including deposit accounts, various loan products, wealth management, and insurance solutions primarily to individual consumers, small and medium-sized enterprises and local community organizations across regional markets in Ohio.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
LCNB vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.9M | $13.2M |
| Net Profit | $5.7M | $-9.8M |
| Gross Margin | — | 86.7% |
| Operating Margin | 29.2% | -24.8% |
| Net Margin | 23.7% | -73.9% |
| Revenue YoY | 5.1% | 59.8% |
| Net Profit YoY | -7.6% | 3.5% |
| EPS (diluted) | $0.40 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.9M | $13.2M | ||
| Q3 25 | $23.8M | $11.6M | ||
| Q2 25 | $22.8M | $11.2M | ||
| Q1 25 | $21.5M | $9.2M | ||
| Q4 24 | $22.7M | $8.3M | ||
| Q3 24 | $21.4M | $7.3M | ||
| Q2 24 | $19.3M | $7.4M | ||
| Q1 24 | $17.8M | $6.5M |
| Q4 25 | $5.7M | $-9.8M | ||
| Q3 25 | $6.9M | $-10.8M | ||
| Q2 25 | $5.9M | $-8.3M | ||
| Q1 25 | $4.6M | $-10.4M | ||
| Q4 24 | $6.1M | $-10.1M | ||
| Q3 24 | $4.5M | $-2.4M | ||
| Q2 24 | $925.0K | $-4.3M | ||
| Q1 24 | $1.9M | $-13.2M |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
| Q4 25 | 29.2% | -24.8% | ||
| Q3 25 | 35.6% | -77.9% | ||
| Q2 25 | 31.6% | -65.4% | ||
| Q1 25 | 25.6% | -79.9% | ||
| Q4 24 | 32.9% | -91.8% | ||
| Q3 24 | 24.9% | -118.9% | ||
| Q2 24 | 4.9% | -111.0% | ||
| Q1 24 | 12.5% | -180.8% |
| Q4 25 | 23.7% | -73.9% | ||
| Q3 25 | 29.1% | -93.5% | ||
| Q2 25 | 26.0% | -73.9% | ||
| Q1 25 | 21.4% | -113.2% | ||
| Q4 24 | 27.0% | -122.4% | ||
| Q3 24 | 21.2% | -32.6% | ||
| Q2 24 | 4.8% | -58.8% | ||
| Q1 24 | 10.7% | -204.5% |
| Q4 25 | $0.40 | $-0.22 | ||
| Q3 25 | $0.49 | $-0.96 | ||
| Q2 25 | $0.41 | $-0.27 | ||
| Q1 25 | $0.33 | $-0.39 | ||
| Q4 24 | $0.44 | $-0.38 | ||
| Q3 24 | $0.31 | $-0.12 | ||
| Q2 24 | $0.07 | $-0.21 | ||
| Q1 24 | $0.15 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $21.6M | $20.4M |
| Total DebtLower is stronger | $104.4M | — |
| Stockholders' EquityBook value | $273.9M | $-33.9M |
| Total Assets | $2.2B | $35.3M |
| Debt / EquityLower = less leverage | 0.38× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $21.6M | $20.4M | ||
| Q3 25 | $35.9M | $22.7M | ||
| Q2 25 | $49.8M | $26.5M | ||
| Q1 25 | $37.7M | $13.0M | ||
| Q4 24 | $35.7M | $8.5M | ||
| Q3 24 | $39.4M | $11.3M | ||
| Q2 24 | $34.9M | $16.5M | ||
| Q1 24 | $33.0M | $4.0M |
| Q4 25 | $104.4M | — | ||
| Q3 25 | $104.7M | — | ||
| Q2 25 | $105.0M | — | ||
| Q1 25 | $104.6M | — | ||
| Q4 24 | $155.2M | — | ||
| Q3 24 | $155.7M | — | ||
| Q2 24 | $162.2M | — | ||
| Q1 24 | $162.6M | — |
| Q4 25 | $273.9M | $-33.9M | ||
| Q3 25 | $269.9M | $-26.7M | ||
| Q2 25 | $263.5M | $-19.4M | ||
| Q1 25 | $258.7M | $-34.4M | ||
| Q4 24 | $253.0M | $-25.9M | ||
| Q3 24 | $253.2M | $-20.4M | ||
| Q2 24 | $245.2M | $-25.3M | ||
| Q1 24 | $233.7M | $-36.0M |
| Q4 25 | $2.2B | $35.3M | ||
| Q3 25 | $2.2B | $36.5M | ||
| Q2 25 | $2.3B | $41.3M | ||
| Q1 25 | $2.3B | $28.6M | ||
| Q4 24 | $2.3B | $24.0M | ||
| Q3 24 | $2.3B | $27.5M | ||
| Q2 24 | $2.4B | $32.4M | ||
| Q1 24 | $2.3B | $17.9M |
| Q4 25 | 0.38× | — | ||
| Q3 25 | 0.39× | — | ||
| Q2 25 | 0.40× | — | ||
| Q1 25 | 0.40× | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | 0.61× | — | ||
| Q2 24 | 0.66× | — | ||
| Q1 24 | 0.70× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $34.4M | $-2.5M |
| Free Cash FlowOCF − Capex | $33.4M | $-2.5M |
| FCF MarginFCF / Revenue | 140.2% | -19.1% |
| Capex IntensityCapex / Revenue | 4.0% | 0.3% |
| Cash ConversionOCF / Net Profit | 6.08× | — |
| TTM Free Cash FlowTrailing 4 quarters | $54.5M | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.4M | $-2.5M | ||
| Q3 25 | $14.0M | $-3.7M | ||
| Q2 25 | $5.5M | $-7.3M | ||
| Q1 25 | $2.2M | $-4.5M | ||
| Q4 24 | $93.2M | $-5.7M | ||
| Q3 24 | $11.9M | $-10.8M | ||
| Q2 24 | $54.9M | $-13.4M | ||
| Q1 24 | $-11.9M | $-10.9M |
| Q4 25 | $33.4M | $-2.5M | ||
| Q3 25 | $13.7M | $-3.9M | ||
| Q2 25 | $5.2M | $-7.4M | ||
| Q1 25 | $2.1M | $-5.3M | ||
| Q4 24 | $89.4M | $-5.8M | ||
| Q3 24 | $10.5M | $-11.0M | ||
| Q2 24 | $53.8M | $-13.5M | ||
| Q1 24 | $-12.8M | $-10.9M |
| Q4 25 | 140.2% | -19.1% | ||
| Q3 25 | 57.4% | -33.9% | ||
| Q2 25 | 23.0% | -66.1% | ||
| Q1 25 | 10.0% | -57.3% | ||
| Q4 24 | 394.0% | -69.7% | ||
| Q3 24 | 49.0% | -149.9% | ||
| Q2 24 | 278.6% | -183.1% | ||
| Q1 24 | -71.8% | -169.3% |
| Q4 25 | 4.0% | 0.3% | ||
| Q3 25 | 1.3% | 1.9% | ||
| Q2 25 | 1.0% | 0.8% | ||
| Q1 25 | 0.3% | 8.2% | ||
| Q4 24 | 16.7% | 0.6% | ||
| Q3 24 | 6.7% | 2.3% | ||
| Q2 24 | 5.9% | 0.8% | ||
| Q1 24 | 4.8% | 1.0% |
| Q4 25 | 6.08× | — | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 0.92× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 15.23× | — | ||
| Q3 24 | 2.63× | — | ||
| Q2 24 | 59.35× | — | ||
| Q1 24 | -6.24× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
